戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 agnosis, and similarities between sepsis and transfusion-related acute lung injury.
2 ken pre- and postoperatively and at onset of transfusion-related acute lung injury.
3 were prospectively screened for the onset of transfusion-related acute lung injury.
4  easily missed and may mimic or coexist with transfusion-related acute lung injury.
5  product may meet the clinical definition of transfusion-related acute lung injury.
6 oagulation pathways involved in the onset of transfusion-related acute lung injury.
7 d fever are noted in patients with suspected transfusion-related acute lung injury.
8 s initially consistent with and diagnosed as transfusion-related acute lung injury.
9 rs2288904 previously shown to associate with transfusion-related acute lung injury.
10            There were 15 of 89 patients with transfusion-related acute lung injury (17%) who died, wh
11                         Of the patients with transfusion-related acute lung injury, 29 of 37 patients
12 ed, whereas 61 of 145 patients with possible transfusion-related acute lung injury (42%) died and 7 o
13                   To reduce the incidence of transfusion-related acute lung injury (ALI), the America
14 usion-related acute lung injury and possible transfusion-related acute lung injury also had a statist
15 he clinical syndrome is attributed solely to transfusion-related acute lung injury and bacterial seps
16                                              Transfusion-related acute lung injury and immunosuppress
17                                      Risk of transfusion-related acute lung injury and mortality in p
18                                Patients with transfusion-related acute lung injury and possible trans
19                                Patients with transfusion-related acute lung injury and possible trans
20 to transfusion-related complications such as transfusion-related acute lung injury and transfusion-as
21               Due to heightened awareness of transfusion-related acute lung injury and volume overloa
22 ding to ABO-incompatible blood transfusion), transfusion-related acute lung injury, and bacterial con
23       However, aged blood products can cause transfusion-related acute lung injury, and better blood
24         Clinical data on the pathogenesis of transfusion-related acute lung injury are sparse.
25 ilant investigation in patients suspected of transfusion-related acute lung injury, as septic transfu
26                     In addition, at onset of transfusion-related acute lung injury, bronchoalveolar l
27                                              Transfusion-related acute lung injury can lead to respir
28                                              Transfusion-related acute lung injury cases (n=16) were
29 mbin-antithrombin complexes were enhanced in transfusion-related acute lung injury cases compared wit
30  plasminogen activator inhibitor-1 levels in transfusion-related acute lung injury cases compared wit
31 and one randomized controlled trial in which transfusion-related acute lung injury cases only involve
32                                           In transfusion-related acute lung injury cases, bronchoalve
33 o define the clinical course and outcomes in transfusion-related acute lung injury cases.
34 tal morbidity and mortality in patients with transfusion-related acute lung injury compared with tran
35 ury (acute respiratory distress syndrome and transfusion-related acute lung injury), for assessment o
36 usion-related acute lung injury and possible transfusion-related acute lung injury had an increased d
37                       Patients with possible transfusion-related acute lung injury had even higher in
38                                Patients with transfusion-related acute lung injury had evidence of mo
39                                Patients with transfusion-related acute lung injury had fever, tachyca
40 studies have shown that aged RBCs can induce transfusion-related acute lung injury in the presence of
41 ts only to HLA-I HCs, is unlikely to produce transfusion-related acute lung injury, in contrast to an
42  transfusion strategy reduces plasma-related transfusion-related acute lung injury incidence and poss
43          Eligible were all studies reporting transfusion-related acute lung injury incidence, all-cau
44                                          For transfusion-related acute lung injury incidence, final a
45                                              Transfusion-related acute lung injury is a life-threaten
46                                              Transfusion-related acute lung injury is characterized b
47                                              Transfusion-related acute lung injury is the leading cau
48                                              Transfusion-related acute lung injury is the leading cau
49                                              Transfusion-related acute lung injury is the leading cau
50                   Recognizing early signs of transfusion-related acute lung injury may aid in the tre
51                                In a model of transfusion-related acute lung injury, polarized neutrop
52                               In conclusion, transfusion-related acute lung injury produced a conditi
53                            Prior to onset of transfusion-related acute lung injury, systemic interleu
54                            Prior to onset of transfusion-related acute lung injury, there is systemic
55  literature that impact our understanding of transfusion related acute lung injury (TRALI) and transf
56                                              Transfusion-related acute lung injury (TRALI) is a form
57                                              Transfusion-related acute lung injury (TRALI) is a life-
58                                              Transfusion-related acute lung injury (TRALI) is a serio
59                                              Transfusion-related acute lung injury (TRALI) is a syndr
60                                              Transfusion-related acute lung injury (TRALI) is a syndr
61                                              Transfusion-related acute lung injury (TRALI) is now the
62                                              Transfusion-related acute lung injury (TRALI) is the lea
63                                              Transfusion-related acute lung injury (TRALI) is the lea
64                                              Transfusion-related acute lung injury (TRALI) is the lea
65                                              Transfusion-related acute lung injury (TRALI) is the lea
66                                              Transfusion-related acute lung injury (TRALI) is the lea
67                                              Transfusion-related acute lung injury (TRALI) is the lea
68                                              Transfusion-related acute lung injury (TRALI) is the mos
69                                              Transfusion-related acute lung injury (TRALI) remains a
70 has attained significant knowledge regarding transfusion-related acute lung injury (TRALI) through th
71                                     The term transfusion-related acute lung injury (TRALI) was coined
72                                              Transfusion-related acute lung injury (TRALI), a form of
73  review is to present the two-event model of transfusion-related acute lung injury (TRALI), a life-th
74                                In a model of transfusion-related acute lung injury (TRALI), Boc2 also
75 reduced to exceedingly low levels in the US, transfusion-related acute lung injury (TRALI), hemolytic
76 od, acute and delayed transfusion reactions, transfusion-related acute lung injury (TRALI), transfusi
77  of neutrophil extracellular traps (NETs) in transfusion-related acute lung injury (TRALI), which is
78 plasma can result in severe, sometimes fatal transfusion-related acute lung injury (TRALI).
79 d clinical literature on the pathogenesis of transfusion-related acute lung injury (TRALI).
80 lood products and is commonly referred to as transfusion-related acute lung injury (TRALI).
81 blood donor products are somehow involved in transfusion-related acute lung injury (TRALI).
82  permeability and is commonly referred to as transfusion-related acute lung injury (TRALI).
83 ood product-management strategies to prevent transfusion-related acute lung injury (TRALI).
84 lished estimates of known transfusion risks: transfusion-related acute lung injury, transfusion-relat
85 ifferential for any patient believed to have transfusion-related acute lung injury with clinical feat

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。